{"id":"W4288051973","doi":"10.1002/cncr.34394","title":"A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: <scp>BilT</scp>‐01","year":2022,"lang":"en","type":"article","venue":"Cancer","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Comprehensive Cancer Center, University of Michigan; Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Nivolumab; Medicine; Ipilimumab; Gemcitabine; Oncology; Biliary tract cancer; Internal medicine; Cisplatin; Randomized controlled trial; Cancer; Phases of clinical research; Chemotherapy; Immunotherapy","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005064359,0.0003632633,0.001635818,0.0002834261,0.00018202,0.00001862847,0.0001242237,0.00009010344,0.0003117633],"category_scores_gemma":[0.0004218235,0.0002945993,0.0002075931,0.0006526117,0.0003549857,0.0001295706,0.000214058,0.0003831004,6.787716e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003948191,"about_ca_system_score_gemma":0.0005883604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002644722,"about_ca_topic_score_gemma":0.002028069,"domain_scores_codex":[0.9974319,0.0002455137,0.000756909,0.0006671106,0.0004103197,0.0004882544],"domain_scores_gemma":[0.9984137,0.0006027367,0.0003238898,0.0003622999,0.0001166708,0.0001806963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8983472,0.0008234783,0.01812044,0.000776198,0.0009571082,0.0001931981,0.00821945,0.0000760548,0.002252953,0.00003530381,0.008416897,0.06178173],"study_design_scores_gemma":[0.9845394,0.002436681,0.003698588,0.0003276044,0.000859766,0.00004392749,0.001604975,0.0008214884,0.0006355596,0.0000637191,0.004775992,0.0001923387],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9334493,0.06146026,0.000005750861,0.0005589723,0.0004720749,0.003227577,0.0001801896,0.00005818869,0.0005877429],"genre_scores_gemma":[0.980718,0.01287829,0.0001140374,0.000317585,0.0002497316,0.002910188,0.00003691445,0.00005720181,0.002718025],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.08619218,"threshold_uncertainty_score":0.9999506,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02302636326951077,"score_gpt":0.318445493622079,"score_spread":0.2954191303525683,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}